Cite
HARVARD Citation
Sakai, K. et al. (2021). Tumor mutation burden as a biomarker for lung cancer patients treated with pemetrexed and cisplatin (the JIPANG‐TR). Cancer science. 112 (1), pp. 388-396. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Sakai, K. et al. (2021). Tumor mutation burden as a biomarker for lung cancer patients treated with pemetrexed and cisplatin (the JIPANG‐TR). Cancer science. 112 (1), pp. 388-396. [Online].